FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000374535> ?p ?o ?g. }

• W2000374535 endingPage "2357" @default.
• W2000374535 startingPage "2343" @default.
• W2000374535 abstract "Oncogenic EGFRvIII is a naturally occurring oncoprotein and is expressed in about 40–50% of human glioblastomas, particularly those that arise de novo. To understand the molecular mechanisms by which this oncoprotein alters transforming phenotypes, and since our previous work indicated that SHP-2 protein tyrosine phosphatase activity modulated EGFRvIII activation and downstream signaling, we examined whether SHP-2 plays a role in EGFRvIII-induced oncogenesis by using both PTEN-deficient U87MG.EGFRvIII and PTEN-intact LN229.EGFRvIII cells. Inhibition of SHP-2 expression by Shp-2 siRNA inhibited cell growth, transformation and altered morphology of these EGFRvIII transformed GBM cells. Ectopic expression of a PTPase-inactive form of SHP-2, SHP-2 C459S, but not its wild-type SHP-2 or either of two SH2 domain mutants, abrogated transformation of EGFRvIII-expressing glioblastomas in soft agar and in nude mice. SHP-2 C459S cells grew slower and exhibited a more flattened morphology with more organized actin stress fibers under both full growth and low serum conditions. Furthermore, shp-2+/− and −/− mouse embryonic fibroblasts (MEFs) could not be transformed by EGFRvIII while shp-2+/+ MEFs displayed a fully transformed phenotype upon introduction of EGFRvIII, again indicating a requirement for functional SHP-2 in EGFRvIII transformation. Moreover, the SHP-2 PTPase activity inhibitor NSC-87877 inhibited endogenous SHP-2 activity, Erk phosphorylation and transformation in both GBM cell lines. EGFRvIII expression recruited SHP-2 to the receptor complex to transduce signals and also increased SHP-2 phosphorylation at Tyr542. Inhibition of EGFRvIII-induced cell growth and transformation by SHP-2 C459S or shp-2 siRNA was mediated by its ability to block cell cycle progression at different phases in these GBM cells. These data indicate that differential activation of SHP-2 phosphorylation at Tyr542 in these two GBM cell lines likely results in increased different PTPase activity and distinct mechanisms of cell cycle progression and SHP-2, in particular its PTPase activity, plays a critical role in EGFRvIII-mediated transformation." @default.
• W2000374535 created "2016-06-24" @default.
• W2000374535 creator A5070796010 @default.
• W2000374535 creator A5071513506 @default.
• W2000374535 creator A5077598197 @default.
• W2000374535 date "2009-08-01" @default.
• W2000374535 modified "2023-10-14" @default.
• W2000374535 title "The protein tyrosine phosphatase SHP-2 is required for EGFRvIII oncogenic transformation in human glioblastoma cells" @default.
• W2000374535 cites W1483016425 @default.
• W2000374535 cites W1566025256 @default.
• W2000374535 cites W1968472053 @default.
• W2000374535 cites W1972775688 @default.
• W2000374535 cites W1973875557 @default.
• W2000374535 cites W1974546646 @default.
• W2000374535 cites W1976100534 @default.
• W2000374535 cites W1988557714 @default.
• W2000374535 cites W1992865738 @default.
• W2000374535 cites W1997508007 @default.
• W2000374535 cites W2000348274 @default.
• W2000374535 cites W2005946075 @default.
• W2000374535 cites W2008119136 @default.
• W2000374535 cites W2013878898 @default.
• W2000374535 cites W2014446732 @default.
• W2000374535 cites W2017892609 @default.
• W2000374535 cites W2023563217 @default.
• W2000374535 cites W2023763994 @default.
• W2000374535 cites W2029315636 @default.
• W2000374535 cites W2029723738 @default.
• W2000374535 cites W2029854123 @default.
• W2000374535 cites W2029911977 @default.
• W2000374535 cites W2033406586 @default.
• W2000374535 cites W2042629507 @default.
• W2000374535 cites W2057985962 @default.
• W2000374535 cites W2060003123 @default.
• W2000374535 cites W2061122212 @default.
• W2000374535 cites W2070705072 @default.
• W2000374535 cites W2071006062 @default.
• W2000374535 cites W2074297726 @default.
• W2000374535 cites W2077737396 @default.
• W2000374535 cites W2080822958 @default.
• W2000374535 cites W2082454341 @default.
• W2000374535 cites W2090695896 @default.
• W2000374535 cites W2097097666 @default.
• W2000374535 cites W2102752109 @default.
• W2000374535 cites W2105606183 @default.
• W2000374535 cites W2108241942 @default.
• W2000374535 cites W2112810120 @default.
• W2000374535 cites W2121539092 @default.
• W2000374535 cites W2122720918 @default.
• W2000374535 cites W2123246366 @default.
• W2000374535 cites W2129595021 @default.
• W2000374535 cites W2130526419 @default.
• W2000374535 cites W2132298090 @default.
• W2000374535 cites W2321588377 @default.
• W2000374535 cites W2326886626 @default.
• W2000374535 cites W2328471123 @default.
• W2000374535 doi "https://doi.org/10.1016/j.yexcr.2009.05.001" @default.
• W2000374535 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2724964" @default.
• W2000374535 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19427850" @default.
• W2000374535 hasPublicationYear "2009" @default.
• W2000374535 type Work @default.
• W2000374535 sameAs 2000374535 @default.
• W2000374535 citedByCount "41" @default.
• W2000374535 countsByYear W20003745352012 @default.
• W2000374535 countsByYear W20003745352013 @default.
• W2000374535 countsByYear W20003745352014 @default.
• W2000374535 countsByYear W20003745352015 @default.
• W2000374535 countsByYear W20003745352017 @default.
• W2000374535 countsByYear W20003745352018 @default.
• W2000374535 countsByYear W20003745352019 @default.
• W2000374535 countsByYear W20003745352020 @default.
• W2000374535 countsByYear W20003745352023 @default.
• W2000374535 crossrefType "journal-article" @default.
• W2000374535 hasAuthorship W2000374535A5070796010 @default.
• W2000374535 hasAuthorship W2000374535A5071513506 @default.
• W2000374535 hasAuthorship W2000374535A5077598197 @default.
• W2000374535 hasBestOaLocation W20003745352 @default.
• W2000374535 hasConcept C104317684 @default.
• W2000374535 hasConcept C11960822 @default.
• W2000374535 hasConcept C153911025 @default.
• W2000374535 hasConcept C178666793 @default.
• W2000374535 hasConcept C2777553839 @default.
• W2000374535 hasConcept C2777609662 @default.
• W2000374535 hasConcept C31033888 @default.
• W2000374535 hasConcept C502942594 @default.
• W2000374535 hasConcept C54355233 @default.
• W2000374535 hasConcept C55493867 @default.
• W2000374535 hasConcept C555283112 @default.
• W2000374535 hasConcept C62112901 @default.
• W2000374535 hasConcept C62478195 @default.
• W2000374535 hasConcept C81885089 @default.
• W2000374535 hasConcept C85528070 @default.
• W2000374535 hasConcept C86554907 @default.
• W2000374535 hasConcept C86803240 @default.
• W2000374535 hasConcept C95444343 @default.
• W2000374535 hasConcept C97037327 @default.
• W2000374535 hasConceptScore W2000374535C104317684 @default.
• W2000374535 hasConceptScore W2000374535C11960822 @default.

• next